BC
BioCardia, Inc.
BCDA · NASDAQ
$1.10 -0.97% (-$0.01)
1M +18.01%
Market Cap $16.4M
P/E Ratio -
Div. Yield -
ROE 569.36%
Piotroski F-Score Weak
1/9Valuation
24 /100
Expensive P/B 6.06x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 43.23%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 246.91%
ROE 569.36%
ROA 154.34%
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 2.09x
Int. coverage N/A
Stability
60 /100
Moderate Beta 0.49x
Rev. volatility 17.92%
EPS volatility 24.83%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BCDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter A. Altman
Employees
17
Headquarters
Sunnyvale
Upcoming events
11 NOV
Earnings
Upcoming earnings report